When palpating the child's cervical lymph nodes, the nurse notes that they are tender, enlarged, and warm. The best explanation for this is:.

The correct answer is choice B. Ask the adolescent, "Why did you come here today?".

Choice A rationale:

Using the adolescent's own words in correct medical terminology to determine the problem is essential for accurate documentation, but it might not be the initial step in determining the chief complaint. The approach in choice B provides an opportunity for the adolescent to express their primary concern in their own terms.

Choice B rationale:

Asking the adolescent, "Why did you come here today?" allows them to voice their main reason for the visit in their own words. This approach respects their autonomy and encourages open communication. It also helps to identify the primary issue from the adolescent's perspective.

Choice C rationale:

While asking for a detailed listing of symptoms is important for a comprehensive health history, it might not be the best way to initially determine the chief complaint. This approach could potentially overwhelm the patient and miss the opportunity for them to express their primary concern.

Choice D rationale:

Interviewing the parent away from the adolescent might be necessary in certain situations, but it is not the best method for determining the adolescent's chief complaint. The adolescent's input is crucial for understanding their own health concerns and developing a patient-centered approach.

The correct answer is choice C. Therapeutic management includes administration of gamma globulin and aspirin.

Choice A rationale:

The child's fever in Kawasaki disease is not usually responsive to antibiotics within 48 hours. Kawasaki disease is an inflammatory condition of blood vessels, and it doesn't typically respond to antibiotics. The fever associated with Kawasaki disease often persists even with appropriate treatment, and the management focuses on reducing inflammation and preventing complications.

Choice B rationale:

Aspirin is not contraindicated in Kawasaki disease. In fact, aspirin is a key component of the therapeutic management of Kawasaki disease. It is used to reduce inflammation and prevent the development of coronary artery aneurysms, a severe complication of the disease. However, the dosing of aspirin in Kawasaki disease is different from its use for pain relief, and it should be administered under medical supervision.

Choice C rationale:

Therapeutic management of Kawasaki disease does include administration of gamma globulin and aspirin. Gamma globulin is given to reduce the risk of coronary artery involvement and aneurysm formation. Aspirin, at a specific dose regimen, is used to decrease inflammation and platelet aggregation, thus preventing clot formation in the coronary arteries.

Choice D rationale:

The principal area of involvement in Kawasaki disease is not the joints. Kawasaki disease primarily affects the blood vessels, particularly the coronary arteries. The inflammation of these arteries can lead to the development of coronary artery aneurysms, which is a critical concern in Kawasaki disease. Joint involvement is not a prominent feature of this condition.